Document is current
Any future updates will be listed below
-
Authors
Fernández-Suárez, Elena
González-del Pozo, María
Méndez-Vidal, Cristina
Martín-Sánchez, Marta
Mena, Marcela
de la Morena-Barrio, Belén
Corral, Javier
Borrego, Salud
Antiñolo, Guillermo
-
Funding
Funding for this research was provided by:
ISCIII (FI19/00091)
Center for Biomedical Network Research on Rare Diseases (CIBERER), Spain (ERF02MOV/2023)
Regional Ministry of Health and Families of the Autonomous Government of Andalusia (RH-0049-2021, PEER-0501-2019)
Precision Medicine Infrastructure associated with Science and Technology - IMPaCT (IMP-0009)
Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Science and Innovation, Spain and co-funded by ERDF (PI21-00244)
Foundation Isabel Gemio/Foundation Cajasol (FGEMIO-2019-01)
- License Information
-
More Information
Article History
Received: 21 February 2024
Accepted: 10 April 2024
First Online: 4 May 2024
Declarations
:
: This study was conducted according to the ethical principles for medical research involving human subjects according to the Declaration of Helsinki (Edinburgh, 2000). Prior to the study, informed consents were collected from all participants or their legal guardians for clinical genetic testing and research studies, which was approved by the Ethical Committees of the University Hospital Virgen del Rocio (Seville) and the University Hospital Virgen Macarena (Seville).
: Consent for publication was obtained from all study subjects.
: The authors declare no competing interests.
